Margaret Bouvier is the owner of Meg Bouvier Medical Writing. Dr. Bouvier obtained a Ph.D. in Biomedical Sciences from the Mt. Sinai School of Medicine in 1995, then became an IRTA fellow at NINDS, where she performed genetic engineering of dopamine precursors for transplant therapies in Parkinson’s disease.

After her fellowship, Dr. Bouvier worked as a staff writer for current NIH Director Dr. Francis Collins at NHGRI. She wrote press, policy, and communications pieces for the Human Genome Project, and contributed to Appropriations Testimony and Budget Justifications to Congress, which help inform her current work as an NIH grantwriter.

In 2007, Dr. Bouvier founded Meg Bouvier Medical Writing, LLC. Her company successfully works with universities, medical centers, and foundations worldwide to improve the way they communicate about their biomedical research. Her unique perspective allows her to understand the research enterprise while also being steeped in the “culture” of the premiere biomedical research agency in the world. She has helped clients land over $200 million in federal funding.

Seven-Year, Multi-Center Clinical Trial Award. Our clients, working at four participating medical centers, will participate in a highly prestigious, multidisciplinary clinical research consortium at the National Institutes of Health (NIH). Their cooperative agreement award money will be used to conduct clinical trials to accelerate the discovery of treatments for critically ill patients.  While the size of the award will depend on the clinical protocols chosen, a typical seven-year clinical trial award runs in the tens of millions of dollars. Dr. Bouvier was the lead writer, editor, and advisor on the U01 submission team from Meg Bouvier Medical Writing.  (2014)

Dr. Bouvier Interviewed For The Journal Nature. Dr. Bouvier was interviewed on impact in grantwriting. The article includes comments from scientists and funding agency administrators from numerous scientific fields and countries. Dr. Bouvier was the only professional grantwriter to participate. Nature is one of the most widely cited journals in science worldwide. http://www.nature.com/naturejobs/science/articles/10.1038/nj7471-397a (2013)

$19 Million NCI Contract. This sole award is for a Biospecimen Core Repository (BCR) providing biospecimen processing services for The Cancer Genome Atlas (TCGA), a signature program of the NIH. The goal of TCGA is to catalog genetic mutations responsible for cancer using genome sequencing and bioinformatics, improving the ability to diagnose, treat, and prevent disease. Dr. Bouvier served as lead writer, editor, and advisor on the proposal development team at ITECS Innovative Consulting. (2012)

$100 Million HRSA Grant. This award, the only one of its kind in the country, constitutes the largest construction grant in university history. The recipients will use the award to construct an innovative cancer hospital that expands access to care and integrates teaching, research, and clinical care on each floor. Dr. Bouvier served as lead writer, editor, and advisor on the application development team from ITECS Innovative Consulting. (2011)

Website LinkedIn Twitter Facebook


Posted December 13, 2010 by Meg Bouvier

%d bloggers like this: